Detalles de la búsqueda
1.
Long-term outcomes of radical prostatectomy versus low-dose-rate brachytherapy in patients with intermediate-risk prostate cancer: Propensity score matched comparison.
Prostate
; 83(2): 135-141, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36176043
2.
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy.
Int J Clin Oncol
; 28(5): 698-706, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814038
3.
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
Int J Clin Oncol
; 28(8): 1092-1100, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227547
4.
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
Int J Clin Oncol
; 28(9): 1200-1206, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37432614
5.
Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrence.
Int J Urol
; 30(12): 1147-1154, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650359
6.
Clinical significance of unfavorable findings in intermediate-risk prostate cancer patients for predicting treatment outcomes after contemporary, dose-escalated multimodal radiotherapy.
Prostate
; 82(4): 433-441, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914134
7.
Prognostic value of PSA bounce after definitive radiotherapy revisited.
Int J Clin Oncol
; 27(2): 411-417, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34677737
8.
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?
Int J Clin Oncol
; 27(1): 184-193, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34599724
9.
Trimodal therapy with high-dose-rate brachytherapy and hypofractionated external beam radiation combined with long-term androgen deprivation for unfavorable-risk prostate cancer.
Strahlenther Onkol
; 197(11): 976-985, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909100
10.
National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastases.
Jpn J Clin Oncol
; 50(10): 1188-1194, 2020 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32627817
11.
Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants.
Antimicrob Agents Chemother
; 63(6)2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962341
12.
Novel Protease Inhibitors Containing C-5-Modified bis-Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2' Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance.
Antimicrob Agents Chemother
; 63(8)2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085520
13.
Potent HIV-1 protease inhibitors incorporating squaramide-derived P2 ligands: Design, synthesis, and biological evaluation.
Bioorg Med Chem Lett
; 29(18): 2565-2570, 2019 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31416666
14.
Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.
Graefes Arch Clin Exp Ophthalmol
; 257(10): 2297-2306, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31377848
15.
GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants.
Antimicrob Agents Chemother
; 62(5)2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29463535
16.
Correction to: Comparison of outcomes in highrisk prostate cancer patients treated with low/highdoserate brachytherapy plus external beam radiotherapy.
Int J Clin Oncol
; 28(12): 1697, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37812316
17.
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.
Int J Clin Oncol
; 23(6): 1148-1159, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934842
18.
Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligands.
Bioorg Med Chem Lett
; 27(21): 4925-4931, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28958624
19.
Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex.
Bioorg Med Chem
; 25(19): 5114-5127, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28434781
20.
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir.
Proc Natl Acad Sci U S A
; 111(33): 12234-9, 2014 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25092296